IP Library › Granted Patent US 8,741,840
Granted Patent B2
US 8,741,840 · App. 12/867,562 · Granted Jun 3, 2014

BMP-7 for use in treating neointimal hyperplasia

Inventors: Keith Hruska (Creve Coeur, MO); Eric T. Choi (St. Louis, MO)
Assignee: Washington University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,840
App. No.
12/867,562
Granted
Jun 3, 2014
Kind
B2
Abstract

The present invention relates to prevention and treatment of vascular sclerosis, vascular calcification (VC) and neointimal hyperplasia using a morphogen.

Claims (3)

1. A method of treating neointimal hyperplasia in a subject suffering therefrom comprising the step of administering to said subject.

2. The method of claim 1 , wherein the neointimal hyperplasia is associated with anastomosis.

3. The method of claim 1 , wherein the neointimal hyperplasia is induced by chronic kidney disease.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 30, 2017
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042114/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2013
From: CHOI, ERIC
To: WASHINGTON UNIVERSITY
Reel/Frame 030777/0904 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2013
From: HRUSKA, KEITH
To: WASHINGTON UNIVERSITY
Reel/Frame 030121/0555 →
Continuity (2)
Provisional Application 61028499 · Feb 13, 2008
Related Publication 20110111054A1 · May 12, 2011